We found that NOVA2 expression is significantly correlated to that of Collagen type IV Alpha 1 Chain (COL4A1), a poor prognosis angiogenic marker for GC (Figure 4A) [82,83], raising the possibility that NOVA2 was selectively overexpressed in tumor ECs. This evidence concerns the gene COL4A1 and gastric cancer.